What is the ticker symbol for Veradermics?

Veradermics trades under the ticker MANE on NYSE.

What sector does Veradermics operate in?

Veradermics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MANE in a portfolio?

PortView shows MANE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Veradermics (MANE) Stock Analysis

NYSEHealthcareBiotechnology

$96.66-0.87%

1-year price historyRange $37.03 – $129.74

52-week range$96.66

$32.00$131.24

What Veradermics does

Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.

Key metrics

Market cap

$4.04B

P/E (TTM)

-30.78

EPS (TTM)

$-3.14

Beta

1.23

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$111.20

200-day avg

$87.04

52-week high

$131.24

52-week low

$32.00

CEO

Reid Waldman

ETFs linked to MANE

Broad-market and Healthcare sector ETFs an investor holding Veradermics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MANE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MANE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Veradermics?: Veradermics trades under the ticker MANE on NYSE.
Which exchange is MANE listed on?: MANE is listed on NYSE.
What sector does Veradermics operate in?: Veradermics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MANE in a portfolio?: PortView shows MANE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.